Clinical Trial Update: Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 safety trial evaluating IRESSA (gefitinib) with cisplatin and radiation therapy in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Iressa (gefitinib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: TERMINATED